Systemic Psoriasis Therapy Linked to Higher Symtomatic UTI Risk in Women
Use of cyclosporine, infliximab, and anti-IL17 agents may be associated with increased risk of symptomatic urinary tract infection in women with psoriasis.
Psoriasis
AAD and NPF Release Clinical Guideline on UV Therapy for Managing Psoriasis
A clinical guideline for the use of phototherapy for the care and management of adult patients with psoriasis developed by the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) has been published.
Biologic Treatment for Psoriasis May Reduce Coronary Inflammation
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography.
Importance of Type vs Number of Comorbidities in Psoriatic Arthritis
Type, rather than number, of comorbidities, has a greater effect on the quality of life of patients with psoriatic arthritis, according to recent research.
Psoriasis Patients Often Use Complementary, Alternative Medicine When Traditional Meds Fail
41, 39.5 percent use alternative, complementary therapies; higher use seen with severe psoriasis.
Abdominal Obesity May Raise Risk for Psoriasis
High waist circumference, regardless of overall body mass index, tied to higher risk.
Higher Risk for Mental Disorders Seen in Patients With Psoriasis
Time to onset found to be 2 to 3 months for anxiety disorders and other conditions.
Apremilast Effective for Patients Dissatisfied With Topical Corticosteroids
Addition of apremilast to a regimen of topical corticosteroids was safe and effective in patients with moderate plaque-type psoriasis.
Treatment Effect of Halobetasol Propionate/Tazarotene Combination Lotion for Plaque Psoriasis
A fixed-dose combination lotion comprised of halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) is more effective for treating moderate-to-severe plaque psoriasis than either component alone.
Halobetasol Propionate/Tazarotene Combination Lotion May Offer Sustained Symptomatic Relief in Plaque Psoriasis
Researchers completed 2 post hoc analyses of large, double-blind trials examining the efficacy of HP/TAZ combination therapy for clinically meaningful outcomes.
Next post in Dermatology Information Center
